Economy
Chulalongkorn Faculty of Medicine Foundation Receives 50 Million Baht Donation for Cell Therapy
Cryoviva (Thailand) and Reviva Cell (Thailand) have donated 50 million baht to the Chulalongkorn Faculty of Medicine Foundation to advance domestic cell therapy production.
On September 3, 2026, Thai Post reported that the Chulalongkorn Faculty of Medicine Foundation received a 50 million baht donation from Cryoviva (Thailand) Co., Ltd. and Reviva Cell (Thailand) Co., Ltd. This collaborative effort between the private sector and the academic institution aims to enhance Thailand's capabilities in producing cell therapies that meet international standards.
For residents and those interested in Thailand’s medical landscape, this development signifies a strengthening of the country’s biotechnology infrastructure. By fostering public-private partnerships, the initiative seeks to elevate the quality and accessibility of advanced medical treatments within the nation. As Thailand continues to position itself as a regional hub for medical excellence, such investments in research and production capacity are key indicators of the country's growing focus on high-tech healthcare solutions.
While the donation has been officially received, specific details regarding the timeline for the implementation of new production facilities or the specific types of cell therapies to be prioritized remain to be confirmed. Observers will be watching to see how this funding translates into tangible clinical advancements and whether it will lead to further collaborations between the private sector and public health institutions in the near future.